Sanofi’s cost containment helps bottom line

Sanofi reported second quarter revenue of €9.1 billion, a gain of 3.9% or €346 million from the year earlier figure. Remarkably, the French pharmaceutical company was able to keep its operating costs at very close to those a year earlier.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

France